Nivolumab and Ipilimumab Combination Therapy for Second-Line Treatment of Hepatocellular Carcinoma

समान संसाधन

• Ipilimumab in combination with nivolumab for the treatment of renal cell carcinoma
  द्वारा: Gao, Xin, और अन्य
  प्रकाशित: (2018)
• Nivolumab plus ipilimumab combination therapy for the first-line treatment NSCLC: evidence to date
  द्वारा: Remon, Jordi, और अन्य
  प्रकाशित: (2019)
• Nivolumab in combination with ipilimumab for the treatment of melanoma
  द्वारा: Somasundaram, Rajasekharan, और अन्य
  प्रकाशित: (2015)
• Combination of nivolumab and ipilimumab in the treatment of disseminated renal cell carcinoma. Realities and prospects
  द्वारा: B. Ya. Alekseev, और अन्य
  प्रकाशित: (2020-09-01)
• Results of combined nivolumab and ipilimumab therapy in patients with cancer
  द्वारा: M. A. Lyadova, और अन्य
  प्रकाशित: (2021-12-01)